2011
DOI: 10.1586/erm.11.7
|View full text |Cite
|
Sign up to set email alerts
|

Prenatal, noninvasive and preimplantation genetic diagnosis of inherited disorders: hemoglobinopathies

Abstract: Disorders of hemoglobin synthesis have been used as a prototype for the development of most approaches for prenatal diagnosis (PND). PND for hemoglobinopathies based on molecular analysis of trophoblast or amniocyte DNA has accumulated approximately 30 years of experience. Disadvantages with conventional PND include 'invasive' fetal sampling and the need to terminate affected ongoing pregnancies. New developments are directed towards improving both the timing and/or safety of procedures. Preimplantation geneti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
22
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(22 citation statements)
references
References 104 publications
(127 reference statements)
0
22
0
Order By: Relevance
“…Future prospects for NIPD include its continued expansion to cover a greater range of disorders, including hemoglobinopathies [22] and fetal and/or neonatal alloimmune thrombocytopenia [23]. The technology also continues to advance beyond qualitative PCR for specific fetal sequences, to include DNA arrays for common SNPs associated with beta-thalassemia [24] and microfluidics digital PCR for relative mutation dosage in hemophilia [25].…”
Section: Nipd Of Fetal Sex and Monogenic Disordersmentioning
confidence: 99%
“…Future prospects for NIPD include its continued expansion to cover a greater range of disorders, including hemoglobinopathies [22] and fetal and/or neonatal alloimmune thrombocytopenia [23]. The technology also continues to advance beyond qualitative PCR for specific fetal sequences, to include DNA arrays for common SNPs associated with beta-thalassemia [24] and microfluidics digital PCR for relative mutation dosage in hemophilia [25].…”
Section: Nipd Of Fetal Sex and Monogenic Disordersmentioning
confidence: 99%
“…For such situations targeted molecular methods are appropriate, selected according to the population‐specific mutation spectrum(s). However, when laboratory infrastructure and expertise allows, more generic methods, such as direct sequencing (for point mutations) and Multiplex Ligation‐dependent Probe Amplification, MLPA (for larger deletions or duplications), are becoming more widely applied, and are particularly relevant to address sample genotyping in multiethnic societies that have resulted from more recent trends of global migration .…”
Section: Conventional Prenatal Diagnosismentioning
confidence: 99%
“…For such situations targeted molecular methods are appropriate, selected according to the population-specific mutation spectrum(s). However, when laboratory infrastructure and expertise allows, more generic methods, such as direct sequencing (for point mutations) and Multiplex Ligation-dependent Probe Amplification, MLPA (for larger deletions or duplications), are becoming more widely applied, and are particularly relevant to address sample genotyping in multiethnic societies that have resulted from more recent trends of global migration [6,7]. In PND, absolute accuracy is fundamental, and is potentially supported by any molecular method, as long as there is strict adherence to the highest laboratory standards (Traeger-Synodinos J, Harteveld CL, Old J, Petrou M, Giordano PC, Galanello R, Angastiniotis M, De la Salle B, in preparation).…”
Section: Conventional Prenatal Diagnosismentioning
confidence: 99%
“…They are caused by mutations that affect genes that coordinate the synthesis of the globin chains of hemoglobin (Hb), thereby resulting in absence or reduced synthesis (thalassemia and hereditary persistence of fetal hemoglobin) or structural changes (sickle cell disease, Hb C, Hb D and Hb E, among others). 1,2 Sickle cell disease and thalassemia are among the commonest hemoglobinopathies. These diseases may occur in isolation or together and cause a wide range of disorders of varying severity.…”
Section: Introductionmentioning
confidence: 99%
“…1,3 The prevalence of hemoglobinopathies varies according to the region and the ethnic composition of the population. In some countries in Europe, Africa and Asia, where there is high incidence of hemoglobinopathies, it is a public health concern, considering that thousands of children are born with these genetic disorders annually.…”
Section: Introductionmentioning
confidence: 99%